Effect of Labetalol for Treating Patients with Pregnancy-Induced Hypertension: A Systematic Review

被引：0
|
作者：
Bej, Punyatoya [1 ]
Das, Sambhunath [2 ]
机构：
[1] Rama Med Coll & Res Ctr, Dept Community Med, Hapur, Uttar Pradesh, India
[2] All India Inst Med Sci, Dept Cardiac Anaesthesia, New Delhi, India
来源：
JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES | 2022年 / 8卷 / 03期
关键词：
Eclampsia; fetal outcome; labetalol; maternal outcome; nifedipine; preeclampsia; pregnancy-induced hypertension; ORAL NIFEDIPINE; INTRAVENOUS LABETALOL; ANTIHYPERTENSIVE TREATMENT; BLOOD-PRESSURE; HYDRALAZINE; METHYLDOPA; EMERGENCY; TRIAL;
D O I：
10.4103/jpcs.jpcs_69_22
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pregnancy-induced hypertension (PIH) is one of the main causes of maternal mortality. Many first- and second-line drugs are available to treat the condition. Labetalol lowers blood pressure by blocking both alpha and beta adrenergic receptors. It preserves uteroplacental blood flow efficiently. A systemic review was carried out to find the efficacy and safety of labetalol in the treatment of PIH. Three thousand twenty-six studies were retrieved in 20 years. Finally, 28 studies were selected after applying the review criteria. Twenty-three studies detected that labetalol had superior or similar action compared to other drugs in controlling hypertension in patients with preeclampsia and eclampsia. The systematic review concluded that labetalol is a safe, effective, first-choice of drug with few side effects in treating PIH.
引用
收藏
页码：144 / 151
页数：8
相关论文
共 50 条
  • [1] LABETALOL PHARMACOKINETICS IN PREGNANCY-INDUCED HYPERTENSION
    ROGERS, RC
    SIBAI, BM
    WHYBREW, WD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 162 (02) : 362 - 366
  • [2] LABETALOL VS METHYLDOPA IN THE TREATMENT OF PREGNANCY-INDUCED HYPERTENSION
    ELQARMALAWI, AM
    MORSY, AH
    ALFADLY, A
    OBEID, A
    HASHEM, M
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1995, 49 (02) : 125 - 130
  • [3] Treatment of pregnancy-induced hypertension compared with labetalol, low dose aspirin and placebo
    Xiang, Xuewen
    Wang, Fang
    Zhao, Ni
    Zhou, Zhao
    CELLULAR AND MOLECULAR BIOLOGY, 2020, 66 (08) : 9 - 13
  • [4] Pregnancy-Induced hypertension
    Kintiraki E.
    Papakatsika S.
    Kotronis G.
    Goulis D.G.
    Kotsis V.
    Hormones, 2015, 14 (2) : 211 - 223
  • [5] Pregnancy-Induced hypertension
    Kintiraki, Evangelia
    Papakatsika, Sophia
    Kotronis, George
    Goulis, Dimitrios G.
    Kotsis, Vasilios
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2015, 14 (02): : 211 - 223
  • [6] Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa
    Molvi, Shaba N.
    Mir, Shahida
    Rana, Vikram S.
    Jabeen, Farhat
    Malik, A. Rauoof
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (06) : 1553 - 1562
  • [7] Latest findings on labetalol in severe hypertension during pregnancy and in postpartum - a systematic review
    Makarewicz, Maciej
    Kasprzak, Jaroslaw D.
    Peruga, Jan Z.
    ARTERIAL HYPERTENSION, 2023, 27 (04): : 207 - 214
  • [8] Comparison of the efficacy of intravenous labetalol versus oral nifedipine in patients with severe pregnancy-induced hypertension beyond 30 weeks of gestation
    Agarwal, Manika
    Rukshana, Makakmayum
    Basu, Ritisha
    Shullai, Wansalan K.
    Singh, Santa A.
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2023, 12 (12) : 3119 - 3122
  • [9] Dietary calcium and pregnancy-induced hypertension: is there a relation?
    Ritchie, LD
    King, JC
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2000, 71 (05) : 1371S - 1374S
  • [10] Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa
    Shaba N. Molvi
    Shahida Mir
    Vikram S. Rana
    Farhat Jabeen
    A. Rauoof Malik
    Archives of Gynecology and Obstetrics, 2012, 285 : 1553 - 1562
12345